Citations

Mayo Clinic

Showing 10 of 108602 citations.

Synergistic interactions of obesity with sex, education, and smoking and accumulation of multi-morbidity (MM) across the lifespan
Chamberlain, Alanna M. , Kapoor, Ekta , Rocca, Walter A. , St Sauver, Jennifer L , Grossardt, Brandon R. , Chamberlain, Alanna M , Rocca, Walter A , Sauver, Jennifer L. St. , Kapoor, Ekta

Journal of Multimorbidity and Comorbidity | February 25, 2023 | Volume: 13 | Issue: No issue available | Pages: No page available

10.1177/26335565231160139 | PMID 36860667 Get It

Objectives Obesity is a potentially modifiable risk factor that has been consistently associated with the development and progression of multi-morbidity (MM). However, obesity may be more problematic for some persons compared to others because of interactions with other risk factors. Therefore, we studied the effect of interactions between patient characteristics and overweight and obesity on the rate of accumulation of MM. Methods We studied 4 cohorts of persons ages 20-, 40-, 60-, and 80-years residing in Olmsted County, Minnesota between 2005 and 2014 using the Rochester Epidemiology Project (REP) medical records-linkage system. Body mass index, sex, race, ethnicity, education, and smoking status were extracted from REP indices. The rate of accumulation of MM was calculated as the number of new chronic conditions accumulated per 10 person years through 2017. Poisson rate regression models were used to identify associations between characteristics and rate of MM accumulation. Additive interactions were summarized using relative excess risk due to interaction, attributable proportion of disease, and the synergy index. Results Greater than additive synergistic associations were observed between female sex and obesity in the 20- and 40-year cohorts, between low education and obesity in the 20-year cohort (both sexes), and between smoking and obesity in the 40-year cohort (both sexes). Conclusions Interventions targeted at women, persons with lower education, and smokers who also have obesity may result in the greatest reduction in the rate of MM accumulation. However, interventions may need to focus on persons prior to mid-life to have the greatest effect.
Impact of second primary malignancy post–autologous transplantation on outcomes of multiple myeloma: a CIBMTR analysis
Ragon, Brittany Knick , Shah, Meera , D’Souza, Anita , Estrada‐Merly, Noel, Gowda, Lohith , George, Gemlyn , Lima, Marcos de , Hashmi, Shahrukh K. , Kharfan‐Dabaja, Mohamed A. , Majhail, Navneet S. , Banerjee, Rahul , Saad, Ayman , Hildebrandt, Gerhard , Mian, Hira , Abid, Muhammad Bilal , Lekakis, Lazaros J. , Strouse, Christopher , Aljurf, Mahmoud , Vesole, David H. , Lee, Cindy H. , Pawarode, Attaphol , Miller, Kevin C. , Holmberg, Leona , Afrough, Aimaz , Solh, Melhem , Munshi, Pashna N. , Anderson, Larry D. , Wirk, Baldeep , Qazilbash, Muzaffar H. , Shah, Nina , Kumar, Shaji , Usmani, Saad Z. , Holmberg, Leona , Shah, Mithun V , de Lima, Marcos , Hashmi, Shahrukh K , Patel, Sagar , Nieto, Yago , Badawy, Sherif M , Dholaria, Bhagirathbhai R , Miller, Kevin C , Nishihori, Taiga , Anderson, Larry D , Kaur, Gurbakhash , Kumar, Shaji K , D'Souza, Anita , Saad, Ayman , Majhail, Navneet S , Banerjee, Rahul , Strouse, Christopher S , Mian, Hira , Usmani, Saad , Abid, Muhammad Bilal , Battiwalla, Minoo , Patel, Sagar S. , Murthy, Hemant S. , Nieto, Yago , Badawy, Sherif M. , Al Hadidi, Samer , Dholaria, Bhagirathbhai , Gergis, Usama , Nishihori, Taiga , Kaur, Gurbakhash

Blood Advances | February 24, 2023 | Volume: 7 | Issue: 12 | Pages: 2746-2757

10.1182/bloodadvances.2022009138 | PMID 36827681 Get It

Abstract The overall survival (OS) has improved significantly in multiple myeloma (MM) over the last decade with the use of proteasome inhibitor and immunomodulatory drug-based combinations, followed by high-dose melphalan and autologous hematopoietic stem cell transplantation (auto-HSCT) and subsequent maintenance therapies in eligible newly diagnosed patients. However, clinical trials using auto-HSCT followed by lenalidomide maintenance have shown an increased risk of second primary malignancies (SPM), including second hematological malignancies (SHM). We evaluated the impact of SPM and SHM on progression-free survival (PFS) and OS in patients with MM after auto-HSCT using CIBMTR registry data. Adult patients with MM who underwent first auto-HSCT in the United States with melphalan conditioning regimen from 2011 to 2018 and received maintenance therapy were included (n = 3948). At a median follow-up of 37 months, 175 (4%) patients developed SPM, including 112 (64%) solid, 36 (20%) myeloid, 24 (14%) SHM, not otherwise specified, and 3 (2%) lymphoid malignancies. Multivariate analysis demonstrated that SPM and SHM were associated with an inferior PFS (hazard ratio [HR] 2.62, P < .001 and HR 5.01, P < .001, respectively) and OS (HR 3.85, P < .001 and HR 8.13, P < .001, respectively). In patients who developed SPM and SHM, MM remained the most frequent primary cause of death (42% vs 30% and 53% vs 18%, respectively). We conclude the development of SPM and SHM leads to a poor survival in patients with MM and is an important survivorship challenge. Given the median survival for MM continues to improve, continued vigilance is needed to assess the risks of SPM and SHM with maintenance therapy post–auto-HSCT.
Osteochondritis Dissecans of the Capitellum of the Elbow: Improved Outcomes in Surgically Treated Versus Nonoperatively Treated Patients at Long‐Term Follow‐up
Braig, Zachary V. , Uvodich, Mason E. , Till, Sara E., Reinholz, Anna K., Morrey, Mark E. , Sánchez‐Sotelo, Joaquín , O’Driscoll, Shawn W. , Camp, Christopher L. , Sanchez-Sotelo, J. , Camp, Christopher L. , Fitzsimmons, James S , Morrey, Mark E

Arthroscopy, Sports Medicine, and Rehabilitation | February 24, 2023 | Volume: 5 | Issue: 2 | Pages: No page available

10.1016/j.asmr.2023.01.011 | PMID 37101861 Get It

Purpose To (1) report the long‐term outcomes associated with both operative and nonoperative management of capitellar osteochondritis dissecans (OCD), (2) identify factors associated with failure of nonoperative management, and (3) determine whether delay in surgery affects final outcomes. Methods All patients who received a diagnosis of capitellar OCD from 1995‐2020 within a geographic cohort were included. Medical records, imaging studies, and operative reports were manually reviewed to record demographic data, treatment strategies, and outcomes. The cohort was divided into 3 groups: (1) nonoperative management, (2) early surgery, and (3) delayed surgery. Delayed surgery (surgery ≥6 months after symptom onset) was considered failure of nonoperative management. Results Fifty elbows with a mean follow‐up period of 10.5 years (median, 10.3 years; range, 1‐25 years) were studied. Of these, 7 (14%) were definitively treated nonoperatively, 16 (32%) underwent delayed surgery after at least 6 months of failed nonoperative treatment, and 27 (54%) underwent early surgical intervention. When compared with nonoperative management, surgical management resulted in superior Mayo Elbow Performance Index pain scores (40.1 vs 33, P = .04), fewer mechanical symptoms (9% vs 50%, P < .01), and better elbow flexion (141° vs 131°, P = .01) at long‐term follow‐up. Older patients trended toward increased failure of nonoperative management ( P = .06). The presence of an intra‐articular loose body predicted failure of nonoperative management ( P = .01; odds ratio, 13). Plain radiography and magnetic resonance imaging had poor sensitivities for identifying loose bodies (27% and 40%, respectively). Differences in outcomes after early versus delayed surgical management were not observed. Conclusions Nonoperative management of capitellar OCD failed 70% of the time. Elbows that did not undergo surgery had slightly more symptoms and decreased functional outcomes compared with those treated surgically. The greatest predictors of failure of nonoperative treatment were older age and presence of a loose body; however, an initial trial of nonoperative treatment did not adversely impact the success of future surgery. Level of Evidence Level III, retrospective cohort study.
Motor Speech Phenotypes in Children With Epilepsy: Preliminary Findings
Stoeckel, Ruth , Olsen, Emily , Tallman, Sarah, Iuzzini-Seigel, Jenya , Allison, Kristen , Stoeckel, Ruth , Iuzzini-Seigel, Jenya , Allison, Kristen M.

American Journal of Speech-Language Pathology | February 24, 2023 | Volume: 32 | Issue: 4S | Pages: 1912-1922

10.1044/2022_ajslp-22-00176 | PMID 36827527 Get It

Purpose: This exploratory study aimed to characterize motor speech impairments in a small sample of children with epilepsy, both with and without a known seizure etiology. A secondary aim was to evaluate the validity of the Profile for Childhood Apraxia of speech and Dysarthria (ProCAD), a newly developed tool for differential diagnosis of childhood apraxia of speech and dysarthria. Method: Thirteen children with seizure disorders completed a comprehensive speech and language assessment. Three expert speech-language pathologists rated the presence of auditory-perceptual features of motor speech impairment using the ProCAD. Motor speech features, diagnoses, and standardized test scores were compared between children with a known seizure etiology and children with idiopathic epilepsy. Results: Nine of the 13 children exhibited motor speech impairment; dysarthria was the most common diagnosis. Most children (11/13) exhibited language impairment. Group comparisons showed that children with a known seizure etiology had more atypical motor speech features and lower language scores than children with idiopathic seizures. Conclusion: These preliminary findings suggest a high rate of motor speech impairment among children with epilepsy.
Reply to the Letter to the Editor: There are Considerable Inconsistencies Among Minimum Clinically Important Differences in TKA: A Systematic Review
Deckey, David G. , Verhey, Jens T. , Gerhart, Coltin R. B. , Christopher, Zachary K. , Spangehl, Mark J. , Clarke, Henry D. , Bingham, Joshua S.

Clinical Orthopaedics & Related Research | February 24, 2023 | Volume: 481 | Issue: 4 | Pages: 843-844

10.1097/corr.0000000000002592 | PMID 36827490 Get It

Determinants of Mortality for Ventilated Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia
Motowski, Hayley, Hampton, Nicholas, Kollef, Marin H. , Micek, Scott T., Ilges, Daniel, Ilges, Dan

Critical Care Explorations | February 24, 2023 | Volume: 5 | Issue: 3 | Pages: e0867

10.1097/cce.0000000000000867 | PMID 36861046 Get It

IMPORTANCE: Hospital-acquired pneumonia (HAP) is the most common hospital-acquired infection, accounting for 22% of all nosocomial infections. The available studies to date have not attempted to assess whether confounding factors may account for the observed difference in mortality for the two forms of nosocomial pneumonia associated with mechanical ventilation, namely ventilated HAP (vHAP) and ventilator-associated pneumonia (VAP). OBJECTIVES: To determine if vHAP is an independent predictor of mortality among patients with nosocomial pneumonia. DESIGN, SETTING, AND PARTICIPANTS: Single-center retrospective cohort study conducted at Barnes-Jewish Hospital, St. Louis, MO, between 2016 and 2019. Adult patients with a pneumonia discharge diagnosis were screened and patients diagnosed with vHAP and VAP were included. All patient data was extracted from the electronic health record. MAIN OUTCOMES AND MEASURES: The primary outcome was 30-day all-cause mortality (ACM). RESULTS: One thousand one-hundred twenty unique patient admissions were included (410 vHAP, 710 VAP). Thirty-day ACM was greater for patients with vHAP compared with VAP (37.1% vs 28.5%; p = 0.003). Logistic regression analysis identified vHAP (adjusted odds ratio [AOR], 1.77; 95% CI, 1.51–2.07), vasopressor use (AOR, 2.34; 95% CI, 1.94–2.82), Charlson Comorbidity Index (1-point increments) (AOR, 1.21; 95% CI, 1.18–1.24), total antibiotic treatment days (1-d increments) (AOR, 1.13; 95% CI, 1.11–1.14), and Acute Physiology and Chronic Health Evaluation II score (1-point increments) (AOR, 1.04; 95% CI, 1.03–1.06) as independent predictors of 30-day ACM. The most common bacterial pathogens identified as causes of vHAP and VAP were Staphylococcus aureus, Enterobacterales species, and Pseudomonas aeruginosa. CONCLUSIONS AND RELEVANCE: In this single-center cohort study with low rates of initial inappropriate antibiotic therapy, vHAP had greater 30-day ACM compared with VAP after adjusting for potential confounding variables including disease severity and comorbidities. This finding suggests that clinical trials enrolling patients with vHAP need to account for this outcome difference in their trial design and data interpretation.
Outcomes of a Large Series of Laparoscopic Ventral Hernia Repairs after Liver Transplantation
Han, Ga-ram , Johnson, Eleanor R., Calderon, Esteban , Hewitt, Winston R. , Harold, Kristi L., Jogerst, Kristen M, Pearson, David G, Jogerst, Kristen M. , Pearson, David G.

The American Surgeon™ | February 24, 2023 | Volume: 89 | Issue: 12 | Pages: 5520-5526

10.1177/00031348231156762 | PMID 36827614 Get It

Background The hernia defects that develop in liver transplant recipients tend to be complex. Unfortunately, there is a paucity of data to guide post-transplant hernia management. Our goal was to evaluate the outcomes following laparoscopic ventral hernia repair (LVHR) in liver transplant recipients. Methods A retrospective review of a prospectively kept database of liver transplant patients at a single tertiary healthcare facility was completed. All patients between 2007 and 2020 who underwent LVHR for a hernia at their transplant incision site were included. The primary outcome studied was hernia recurrence. Secondary outcomes included time-to-hernia repair, complications, and length of stay (LOS). Results There were 89 patients who met inclusion criteria. 82% were male, mean age was 60 years, and mean body mass index was 30.2 kg/m 2 . 94.4% were on tacrolimus and 36% on mycophenolate mofetil. Median time-to-hernia repair was 16 months with a mean mesh size of 743 cm 2 and length of stay of 3.7 days. None required conversion to an open operation. Postoperative complications included ileus (20.2%), acute kidney injury (11.2%), pneumonia (6.7%), and bleeding requiring re-operation (1.1%). Hernia-related complications included chronic suture site pain (1.1%), seroma requiring intervention (3.3%), surgical site infection (3.3%), nonoperative mesh infection (1.1%), and mesh infection requiring explantation (1.1%). Median follow-up was 23 months. Hernia recurrence occurred in 4.5% and no predictive variables for recurrence were identified. Conclusions Although the hernia defects that develop in liver transplant recipients are complex and their comorbidities significant, LVHR can safely and effectively repair these defects with low rates of recurrence and complications.
Presentation and Surgical Management of Multiple Ligament Knee Injuries
Poploski, Kathleen M. , Lynch, Andrew D. , Burns, Travis C. , Harner, Christopher D. , Levy, Bruce A. , Owens, Brett D. , Richter, Dustin L. , Musahl, Volker , Irrgang, James J. , Network, the STaR Trial for Multiple Ligament Knee Injuries, Musahl, Volker , Irrgang, James J , Schenck, Robert C. , Network, the STaR Trial for Multiple Ligament Knee Injuries

Journal of Bone and Joint Surgery | February 24, 2023 | Volume: 105 | Issue: 8 | Pages: 607-613

10.2106/jbjs.20.02051 | PMID 36827383 Get It

Update This article was updated on May 12, 2023, because of a previous error. In the Note on page 612, Byson P. Lesniak, MD, had not been listed as a member of the STaR Trial for Multiple Ligament Knee Injuries Network. The Note now reads “The STaR Trial for Multiple Ligament Knee Injuries Network includes Robert Arciero, MD; Brandee S. Black, MD; Catherine M. Coady, MD, FRSCS; Jonathan M. Cooper, DO; Katherine J. Coyner, MD; Cory M. Edgar, MD, PhD; Al M.J. Getgood, MD, FRCS(Tr&Orth); Joe M. Hart, PhD, ATC; Jonathan D. Hodax, MD, MS; Jonathan D. Hughes, MD; Cale A. Jacobs, PhD, ATC; Darren L. Johnson, MD; Ryan M. Khan, MSc, CCRP; Byson P. Lesniak, MD; Jeffrey A. Macalena, MD; Robert G. Marx, MD; Mark D. Miller, MD; Bradley Nelson, MD; Alicia Oostdyk, PhD; Charity G. Patterson, PhD, MSPH; Adam J. Popchak, PT, PhD; Anil S. Ranawat, MD; Michael J. Stuart, MD; Caroline E. Taber, AB; Ryan J. Warth, MD; Daniel B. Whelan, MD, MSc, FRCSC; and Isabel Wolfe, BS.” An erratum has been published: J Bone Joint Surg Am. 2023 Jun 21;105(12):e33. Background: Multiple ligament knee injuries (MLKIs) represent a spectrum of injury patterns that are often associated with concomitant musculoskeletal and neurovascular injuries, complex treatment, and postoperative complications. However, there has not been high-level evidence describing the presentation and treatment of MLKIs. The purpose of this multicenter retrospective study was to describe characteristics of MLKIs, their management, and related complications using a pathoanatomic MLKI classification system based on the Schenck Knee Dislocation classification system. Methods: This review identified and analyzed MLKIs that occurred between 2011 and 2015. Cases with an MLKI were included in this study if there was a complete tear of ≥2 ligaments and at least 1 ligament was repaired or reconstructed. Cases in which a ligament was deemed clinically incompetent due to a partial ligament tear and required surgical repair or reconstruction were considered equivalent to grade-III tears for inclusion and classification. Demographic information, the mechanism of injury, times from injury to presentation to an orthopaedic surgeon and to surgery, the ligament injury pattern, associated injuries, surgical procedures, and complications were captured. Data were analyzed descriptively. Results: A total of 773 individuals from 14 centers who underwent surgery for an MLKI were reviewed. The mean age of the individuals was 30.5 ± 12.7 years, and 74.2% were male. The most common mechanism involved sports (43.2%). The median time from injury to presentation to the orthopaedic surgeon was 11 days (interquartile range [IQR], 3 to 48 days), and the time to initial ligament surgery was 64 days (IQR, 23 to 190 days). While the most common injury patterns were an anterior cruciate ligament tear combined with either a medial-sided (MLK 1-AM, 20.7%) or lateral-sided (MLK 1-AL, 23.2%) injury, one-third (34.7%) were bicruciate injuries. Associated injuries most often involved menisci (55.6%), nerves (18.5%) and tendons (15.6%). The method of surgical intervention (repair versus reconstruction), external fixator use, and staging of procedures varied by MLKI classification. Loss of motion (11.4%) was the most common postoperative complication. Conclusions: A better understanding of the clinical characteristics and management of the various MLKI patterns can be used to support clinical decision-making and individualized treatment of these complex injuries, and may ultimately lead to enhanced outcomes and reduced associated risks. Level of Evidence: Therapeutic Level IV . See Instructions for Authors for a complete description of levels of evidence.
Timing of CAR-T therapy in follicular lymphoma
Moustafa, Muhamad Alhaj , Moustafa, Muhamad Alhaj

Expert Review of Anticancer Therapy | February 24, 2023 | Volume: 23 | Issue: 4 | Pages: 347-349

10.1080/14737140.2023.2185222 | PMID 36825538 Get It

Editorial Comment
Lyon, Timothy D. , Pathak, Ram A. , Zganjar, Andrew , Zganjar, Andrew J., Lyon, Timothy D

Journal of Urology | February 24, 2023 | Volume: 209 | Issue: 5 | Pages: 870-871

10.1097/ju.0000000000003202.01 | PMID 36825456 Get It